Peytant Solutions

Executive Summary

Peytant Solutions is a San Francisco-based digital health and AI/ML company, though its core focus is the AMStent System, a proprietary airway stent designed for patients with pulmonary obstructions. Pre-clinical outcomes demonstrate that the AMStent System significantly reduces mucus accumulation, stent migration, inflammation, and granuloma formation compared to a commercially available control stent. These results address major complications associated with traditional airway stents, potentially improving patient quality of life and reducing healthcare costs. The company is currently in the 'Approved' stage, indicating that the AMStent System has received regulatory clearance, likely from the FDA. Founded in 2018, Peytant Solutions remains private with limited disclosed financials, but its technology holds promise in a niche market within interventional pulmonology. The company's focus on clinical outcomes and its differentiation from existing solutions position it for potential commercial traction and partnerships with hospitals and medical device distributors.

Upcoming Catalysts (preview)

• Q3 2026First commercial launch and initial sales of AMStent System70% success
• Q4 2026Publication of pivotal clinical trial results in peer-reviewed journal60% success
• TBDStrategic partnership or distribution agreement with major medical device company50% success